• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Crucell ADR

Crucell ADR

  1. All
  2. 3rd Party
  3. Investing
  1. Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola Vaccine Regimen

    Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola Vaccine Regimen

  2. Research and Markets: Influenza A Infections - Pipeline Review, H2 2014

    Research and Markets: Influenza A Infections - Pipeline Review, H2 2014

  3. Research and Markets: Rabies - Pipeline Review, H1 2014

    Research and Markets: Rabies - Pipeline Review, H1 2014

  4. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

  5. Biotech Investing for the Long Haul

    Three ways to separate long-term winners from stocks that fizzle.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.